Novo’s Ozempic Seen as Shoo-In for Next Round of Medicare Price Negotiations
By Greg Slabodkin for BioSpace on Septermber 25, 2024 Novo Nordisk’s blockbuster type 2 diabetes medication is a sure bet
Read MoreBy Greg Slabodkin for BioSpace on Septermber 25, 2024 Novo Nordisk’s blockbuster type 2 diabetes medication is a sure bet
Read MoreBy Kate Ashford on September 24, 2024 for Floyd County Chronicle It’s always important for people to compare plans during
Read Moreby Myles McNamara | Sep 25, 2024 | With Your Family in Mind for Santa Clarita Magazine I touched on this last month, but
Read MoreBy Bob Carlson, Senior Contributor for Forbes on September 25, 2024 For the first time since 2006, the Centers for
Read Moreby David Raths for healthcare innovation on September 24, 2024 Telehealth Modernization Act would also extend Acute Hospital Care at
Read MoreBy Susan Rupe for InsuranceNewsNet.com Inc. on September 25, 2024 Deb Nelson is reassuring her Medicare Advantage clients that the
Read MoreBy Juie Bataille for Medical Economics on September 23, 2024 Value-based care (VBC) is a health care payment model that shifts the
Read MoreBy Eric Revell for FOX Business Spending on federal health care programs has surged in recent years amid the aging of America’s populations,
Read Moreposted by OIG Report September 24, 2024 Why OIG Did This Review Notice: The link provided above connects readers to the
Read MoreMy sister called me in tears after her first supplemental oxygen delivery. It was July 2013. At the time, she
Read More